Strides Arcolab’s arm gets USFDA nod for Oxaliplatin injection

24 Nov 2011 Evaluate

Strides Arcolab’s subsidiary - Onco Therapies has got a tentative approval of US Food and Drug Administration (USFDA) for generic Oxaliplatin injection. The tentative approval is for 50 mg and 100 mg strengths of the injection.

Oxaliplatin is a platinum-based complex that is prescribed in chemotherapy treatment of colorectal cancer and marketed by French pharmaceutical company Sanofi-Aventis under the brand name Eloxatin.

Recently, Onco Therapies had received USFDA approval for Carboplatin Injection 10 mg/mL packaged in 50mg/mL, 150mg/mL, 450 mg/45 mL and 600 mg/60 mL Multi-dose vials.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

901.35 -8.40 (-0.92%)
31-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1272.00
Cipla 1507.30
Zydus Lifesciences 912.75
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×